Brief: Ipca Labs says The global Fund selected co as panel supplier of anti-malarial medicines
10/11/2017 10:46
Nov 10 (Reuters) - Ipca Laboratories Ltd IPCA.NS
* The global Fund selected co as panel supplier of
anti-malarial
medicines
Source text - http://bit.ly/2zwhueB
Further company coverage: IPCA.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees